NICE recommendation expands patient eligibility for AbbVie’s Ozurdex
12th August 2022 Uncategorised 0Treatment becomes an option for treating visual impairment caused by diabetic macular oedema, regardless of lens status
More: NICE recommendation expands patient eligibility for AbbVie’s Ozurdex
Source: News
